We can't afford to have companies withdraw from infectious disease research—it's crucial for global health security
In Conversation
Maintaining independence is paramount because we must never be beholden, in any way, to either industry interests or governmental influence.
In 2022, French food supplement exports grew by 20 percent to over EUR 2.5 billion
The 2030 goals are not the last mile, and the lack of political will to work towards achieving them is a big concern
What gives me hope is the incredible progress in the scientific tools at our disposal and our understanding of what we are after
We are in the business of excellent clinical evidence. EMA wants to partner with stakeholders, including those from industry, to drive up the quality of evidence…
We need to engage more, explain the system, and clarify the steps that we are taking
What does AI really mean? How can we make the equipment safe? The solution will be to start with low hanging fruit where risk is low…
Our motto is simple yet ambitious—everything for everyone, everywhere. I wish for peace, health, and reflection on our shared humanity in these challenging times
We aim to positively surprise our customers and partners with innovative approaches
It's important not to forget the significant contributions made by the pharmaceutical industry during the pandemic. The promises and commitments made by industry players and governments…
While generics continue to be a core focus, there has been a strategic shift towards emphasising innovation
